Get Premium Data for Cyber Monday: Up to 55% Off InvestingProCLAIM SALE

Max Healthcare Institute Ltd (MAXE)

BSE
Currency in INR
1,097.05
+1.70(+0.16%)
Closed

MAXE Income Statement

Advanced Income Statement
Period Ending:
2015
31/03
2016
31/03
2017
31/03
2018
31/03
2019
31/03
2020
31/03
2021
31/03
2022
31/03
2023
31/03
2024
31/03
Total Revenues
aa.aaaa.aaaa.aaaa.aaaa.aa10,590.325,079.739,365.545,62654,060.2
Total Revenues Growth
aa.aaaa.aaaa.aaaa.aaaa.aa-37.48%+136.82%+56.96%+15.9%+18.49%
Cost Of Revenues
aa.aaaa.aaaa.aaaa.aaaa.aa4,689.212,324.417,480.517,313.620,529.2
Gross Profit
aa.aaaa.aaaa.aaaa.aaaa.aa5,901.112,755.321,88528,312.433,531
Gross Profit Growth
aa.aaaa.aaaa.aaaa.aaaa.aa-30.66%+116.15%+71.58%+29.37%+18.43%
Gross Profit Margin %
aa.aaaa.aaaa.aaaa.aaaa.aa55.72%50.86%55.59%62.05%62.03%
Other Operating Expenses, Total
aa.aaaa.aaaa.aaaa.aaaa.aa5,418.910,324.814,305.418,072.220,777.9
Other Operating Expenses, Total Growth
R&D Expenses
Selling General & Admin Expenses
Other Operating Expenses
aa.aaaa.aaaa.aaaa.aaaa.aa-31.76%+90.53%+38.55%+26.33%+14.97%
aa.aaaa.aaaa.aaaa.aaaa.aa-----
aa.aaaa.aaaa.aaaa.aaaa.aa3,048.55,656.78,729.29,863.111,168.9
aa.aaaa.aaaa.aaaa.aaaa.aa1,9142,927.23,3655,887.27,159.2
Operating Income
aa.aaaa.aaaa.aaaa.aaaa.aa482.22,430.57,579.610,240.212,753.1
Operating Income Growth
aa.aaaa.aaaa.aaaa.aaaa.aa-15.27%+404.04%+211.85%+35.1%+24.54%
EBIT Margin %
aa.aaaa.aaaa.aaaa.aaaa.aa4.55%9.69%19.25%22.44%23.59%
Net Interest Expenses
aa.aaaa.aaaa.aaaa.aaaa.aa-412.9-942.7-149.2410.61,116.4
Net Interest Expenses Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+13.42%-128.31%+84.17%+375.2%+171.89%
Interest Expense, Total
aa.aaaa.aaaa.aaaa.aaaa.aa-781.9-1,710-900.1-713.2-445.6
Interest And Investment Income
aa.aaaa.aaaa.aaaa.aaaa.aa369767.3750.91,123.81,562
Other Non Operating Expenses, Total
aa.aaaa.aaaa.aaaa.aaaa.aa459.715.7203.984.344.6
EBT, Excl. Unusual Items
aa.aaaa.aaaa.aaaa.aaaa.aa5291,503.57,634.310,735.113,914.1
Gain (Loss) On Sale Of Assets
aa.aaaa.aaaa.aaaa.aaaa.aa-0.7-2.4-30.613.34.5
Other Unusual Items, Total
aa.aaaa.aaaa.aaaa.aaaa.aa60.3-2,040.3-124.4-111.2-265.4
EBT, Incl. Unusual Items
aa.aaaa.aaaa.aaaa.aaaa.aa588.6-9177,38910,637.213,653.2
EBT, Incl. Unusual Items Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+607.45%-255.79%+905.78%+43.96%+28.35%
EBT, Incl. Unusual Items Margin
aa.aaaa.aaaa.aaaa.aaaa.aa5.56%-3.66%18.77%23.31%25.26%
Income Tax Expense
aa.aaaa.aaaa.aaaa.aaaa.aa-1.3458.51,338.5-397.93,076.8
Net Income to Company
aa.aaaa.aaaa.aaaa.aaaa.aa589.9-1,375.56,050.511,035.110,576.4
Minority Interest
aa.aaaa.aaaa.aaaa.aaaa.aa-----
Net Income
aa.aaaa.aaaa.aaaa.aaaa.aa589.9-1,375.56,050.511,035.110,576.4
Net Income Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+2,059.8%-333.18%+539.88%+82.38%-4.16%
Net Income Margin %
aa.aaaa.aaaa.aaaa.aaaa.aa5.57%-5.48%15.37%24.19%19.56%
Preferred Dividend and Other Adjustments
aa.aaaa.aaaa.aaaa.aaaa.aa-----
Net Income to Common Excl. Extra Items
aa.aaaa.aaaa.aaaa.aaaa.aa589.9-1,375.56,050.511,035.110,576.4
Basic EPS - Continuing Operations
aa.aaaa.aaaa.aaaa.aaaa.aa1.01-1.596.2511.3810.89
Basic EPS - Continuing Operations Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+1,902.48%-257.79%+492.47%+81.89%-4.3%
Diluted EPS - Continuing Operations
aa.aaaa.aaaa.aaaa.aaaa.aa1.01-1.596.2411.3610.84
Diluted EPS - Continuing Operations Growth
aa.aaaa.aaaa.aaaa.aaaa.aa+1,783.1%-257.79%+491.59%+82.05%-4.58%
Basic Weighted Average Shares Outstanding
aa.aaaa.aaaa.aaaa.aaaa.aa584.14863.2967.47970.06971.57
Diluted Weighted Average Shares Outstanding
aa.aaaa.aaaa.aaaa.aaaa.aa584.14863.2969.38971.71975.46
Dividend Per Share
aa.aaaa.aaaa.aaaa.aaaa.aa---11.5
Dividend Per Share Growth
aa.aaaa.aaaa.aaaa.aaaa.aa----+50%
EBITDA
aa.aaaa.aaaa.aaaa.aaaa.aa873.93,895.59,465.312,225.714,819.1
EBITDA Growth
aa.aaaa.aaaa.aaaa.aaaa.aa-42.61%+345.76%+142.98%+29.16%+21.21%
EBITDA Margin %
aa.aaaa.aaaa.aaaa.aaaa.aa8.25%15.53%24.04%26.8%27.41%
EBIT
aa.aaaa.aaaa.aaaa.aaaa.aa